105 related articles for article (PubMed ID: 3118102)
1. Expression of B cell activation antigens on normal and malignant B cells.
Freedman AS; Boyd AW; Berrebi A; Horowitz JC; Levy DN; Rosen KJ; Daley J; Slaughenhoupt B; Levine H; Nadler LM
Leukemia; 1987 Jan; 1(1):9-15. PubMed ID: 3118102
[TBL] [Abstract][Full Text] [Related]
2. Dual fluorochrome analysis of human B lymphocytes: phenotypic examination of resting, anti-immunoglobulin stimulated, and in vivo activated B cells.
Anderson KC; Roach JA; Daley JF; Schlossman SF; Nadler LM
J Immunol; 1986 May; 136(10):3612-8. PubMed ID: 3084636
[TBL] [Abstract][Full Text] [Related]
3. Immunologic markers in non-Hodgkin's lymphoma.
Freedman AS; Nadler LM
Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
[TBL] [Abstract][Full Text] [Related]
4. Studies of in vitro activation and differentiation of human B lymphocytes. I. Phenotypic and functional characterization of the B cell population responding to anti-Ig antibody.
Boyd AW; Anderson KC; Freedman AS; Fisher DC; Slaughenhoupt B; Schlossman SF; Nadler LM
J Immunol; 1985 Mar; 134(3):1516-23. PubMed ID: 3871451
[TBL] [Abstract][Full Text] [Related]
5. Idiotypic immunoglobulin secretion by human B cell non-Hodgkin's lymphomas is related to the expression of the interleukin-2 receptor.
Vyth-Dreese FA; Dellemijn TA; Hekman A; Melief CJ
Leukemia; 1988 Apr; 2(4):231-5. PubMed ID: 3129622
[TBL] [Abstract][Full Text] [Related]
6. Activation and differentiation antigen expression in B-cell non-Hodgkin's lymphoma.
Salter DM; Krajewski AS; Cunningham S
J Pathol; 1988 Mar; 154(3):209-22. PubMed ID: 3280770
[TBL] [Abstract][Full Text] [Related]
7. B5, a new B cell-restricted activation antigen.
Freedman AS; Boyd AW; Anderson KC; Fisher DC; Schlossman SF; Nadler LM
J Immunol; 1985 Apr; 134(4):2228-35. PubMed ID: 2579134
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of cell activation markers after stimulation of resting human B lymphocytes.
Kehrl JH; Muraguchi A; Fauci AS
J Immunol; 1984 Jun; 132(6):2857-61. PubMed ID: 6427329
[TBL] [Abstract][Full Text] [Related]
9. Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes.
Zambello R; Cassatella MA; Trentin L; Bulian P; Siviero F; Feruglio C; Agostini C; Vespignani M; Chisesi T; Pizzolo G
Leukemia; 1991 Nov; 5(11):942-50. PubMed ID: 1835747
[TBL] [Abstract][Full Text] [Related]
10. B7, a B-cell-restricted antigen that identifies preactivated B cells.
Freedman AS; Freeman G; Horowitz JC; Daley J; Nadler LM
J Immunol; 1987 Nov; 139(10):3260-7. PubMed ID: 3500211
[TBL] [Abstract][Full Text] [Related]
11. The acquisition of cytokine responsiveness by murine B cells: a role for antigen and IL-5 in the induction of IL-2 receptors.
Poudrier J; Owens T
Immunology; 1994 Mar; 81(3):373-80. PubMed ID: 8206511
[TBL] [Abstract][Full Text] [Related]
12. Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T cell-B-cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help.
Lederman S; Yellin MJ; Inghirami G; Lee JJ; Knowles DM; Chess L
J Immunol; 1992 Dec; 149(12):3817-26. PubMed ID: 1281189
[TBL] [Abstract][Full Text] [Related]
13. Surface marker expression of human B-cell lymphomas.
Ishii Y; Kokai Y; Yamaguchi A; Tsubota H; Kikuchi K
AIDS Res; 1986 Dec; 2 Suppl 1():S87-93. PubMed ID: 3493786
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of activation and differentiation antigen expression in B-cell non-Hodgkin's lymphoma.
Salter DM; Krajewski AS; Sheehan T; Turner G; Cuthbert RJ; Mclean A
J Pathol; 1989 Nov; 159(3):211-20. PubMed ID: 2593045
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the mechanisms of T cell-dependent polyclonal activation of human B cells. Induction of human B cell responses by fixed activated T cells.
Tohma S; Lipsky PE
J Immunol; 1991 Apr; 146(8):2544-52. PubMed ID: 1707911
[TBL] [Abstract][Full Text] [Related]
16. [Flow cytometric analysis of surface phenotypes in B-cell non-Hodgkin's lymphoma].
Chubachi A
Rinsho Ketsueki; 1989 Dec; 30(12):2134-40. PubMed ID: 2516139
[TBL] [Abstract][Full Text] [Related]
17. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
[TBL] [Abstract][Full Text] [Related]
18. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
19. Expression and the functional role of a p70/75 interleukin 2-binding molecule in human B cell.
Saiki O; Tanaka T; Doi S; Kishimoto S
J Immunol; 1988 Feb; 140(3):853-8. PubMed ID: 2828472
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the expression of IL 2 receptors by human T and B cells: induction by the polyclonal mitogens, phorbol myristate acetate, and anti-mu antibody.
Suzuki T; Cooper MD
J Immunol; 1985 May; 134(5):3111-9. PubMed ID: 2580014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]